Guidance for Industry - Priority Review of Drug Submissions
This guidance aims to articulate Health Canada's expectations and generate a level of consistency regarding the interpretation of the Priority Review of Drug Submissions policy and the filing of a Priority Review request. Additional clarification of the process by which the Priority Review request is assessed is provided.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-07
Data overview
- Formats
- HTML
- File languages
- English, French